EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 21.99 billion. The enterprise value is 18.29 billion.
Market Cap | 21.99B |
Enterprise Value | 18.29B |
Important Dates
The last earnings date was Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 305.41 million shares outstanding. The number of shares has increased by 0.41% in one year.
Current Share Class | n/a |
Shares Outstanding | 305.41M |
Shares Change (YoY) | +0.41% |
Shares Change (QoQ) | -0.08% |
Owned by Insiders (%) | 1.41% |
Owned by Institutions (%) | 7.52% |
Float | 195.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 21.85 |
PB Ratio | 2.38 |
P/TBV Ratio | 2.38 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -26.19 |
EV / Sales | 18.13 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -14.83 |
Financial Position
The company has a current ratio of 6.28, with a Debt / Equity ratio of 0.10.
Current Ratio | 6.28 |
Quick Ratio | 5.46 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | -0.73 |
Interest Coverage | -148.34 |
Financial Efficiency
Return on equity (ROE) is -7.25% and return on invested capital (ROIC) is -5.78%.
Return on Equity (ROE) | -7.25% |
Return on Assets (ROA) | -5.41% |
Return on Invested Capital (ROIC) | -5.78% |
Return on Capital Employed (ROCE) | -9.61% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.09 |
Inventory Turnover | 1.24 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.84% in the last 52 weeks. The beta is 0.75, so EirGenix's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | -18.84% |
50-Day Moving Average | 78.62 |
200-Day Moving Average | 83.74 |
Relative Strength Index (RSI) | 34.87 |
Average Volume (20 Days) | 258,847 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.01 billion and -698.34 million in losses. Loss per share was -2.28.
Revenue | 1.01B |
Gross Profit | 218.99M |
Operating Income | -953.80M |
Pretax Income | -696.51M |
Net Income | -698.34M |
EBITDA | -689.66M |
EBIT | -953.80M |
Loss Per Share | -2.28 |
Balance Sheet
The company has 4.60 billion in cash and 901.30 million in debt, giving a net cash position of 3.70 billion or 12.10 per share.
Cash & Cash Equivalents | 4.60B |
Total Debt | 901.30M |
Net Cash | 3.70B |
Net Cash Per Share | 12.10 |
Equity (Book Value) | 9.26B |
Book Value Per Share | 30.31 |
Working Capital | 5.00B |
Cash Flow
In the last 12 months, operating cash flow was -311.44 million and capital expenditures -921.67 million, giving a free cash flow of -1.23 billion.
Operating Cash Flow | -311.44M |
Capital Expenditures | -921.67M |
Free Cash Flow | -1.23B |
FCF Per Share | -4.04 |
Margins
Gross margin is 21.70%, with operating and profit margins of -94.53% and -69.21%.
Gross Margin | 21.70% |
Operating Margin | -94.53% |
Pretax Margin | -69.03% |
Profit Margin | -69.21% |
EBITDA Margin | -68.35% |
EBIT Margin | -94.53% |
FCF Margin | n/a |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.41% |
Shareholder Yield | -0.41% |
Earnings Yield | -3.18% |
FCF Yield | -5.61% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
EirGenix has an Altman Z-Score of 10.12.
Altman Z-Score | 10.12 |
Piotroski F-Score | n/a |